# Becton Dickinson & Co: financial statements, quarterly

BDX · NYSE · CIK 10795 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/bdx.md) · [Financials](/companies/bdx/financials.md) · [Filings](/companies/bdx/filings.md) · [Insiders](/companies/bdx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bdx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,087 d](/filings/0000010795-25-000099.md) | [4,706](/filings/0000010795-25-000022.md) | [5,045](/filings/0000010795-25-000039.md) | [4,990](/filings/0000010795-25-000072.md) | [5,437 d](/filings/0000010795-25-000099.md) | [5,168](/filings/0000010795-26-000005.md) | [4,480](/filings/0000010795-26-000026.md) | [4,726](/filings/0000010795-26-000035.md) | [8,301 d](/filings/0000010795-25-000099.md) | [5,252](/filings/0000010795-26-000005.md) | [4,714](/filings/0000010795-26-000026.md) | [4,983](/filings/0000010795-26-000035.md) |
| Cost of revenue | $m | [3,386 d](/filings/0000010795-25-000099.md) | [2,679](/filings/0000010795-25-000022.md) | [2,741](/filings/0000010795-25-000039.md) | [2,683](/filings/0000010795-25-000072.md) | [2,950 d](/filings/0000010795-25-000099.md) | [2,933](/filings/0000010795-26-000005.md) | [2,619](/filings/0000010795-26-000026.md) | [2,491](/filings/0000010795-26-000035.md) | [4,269 d](/filings/0000010795-25-000099.md) | [2,841](/filings/0000010795-26-000005.md) | [2,560](/filings/0000010795-26-000026.md) | [2,668](/filings/0000010795-26-000035.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [281 d](/filings/0000010795-25-000099.md) | [290](/filings/0000010795-25-000022.md) | [299](/filings/0000010795-25-000039.md) | [299](/filings/0000010795-25-000072.md) | [302 d](/filings/0000010795-25-000099.md) | [343](/filings/0000010795-26-000005.md) | [232](/filings/0000010795-26-000026.md) | [230](/filings/0000010795-26-000035.md) | [559 d](/filings/0000010795-25-000099.md) | [306](/filings/0000010795-26-000005.md) | [249](/filings/0000010795-26-000026.md) | [258](/filings/0000010795-26-000035.md) |
| Selling, general and administrative | $m | [1,138 d](/filings/0000010795-25-000099.md) | [1,213](/filings/0000010795-25-000022.md) | [1,193](/filings/0000010795-25-000039.md) | [1,196](/filings/0000010795-25-000072.md) | [1,256 d](/filings/0000010795-25-000099.md) | [1,318](/filings/0000010795-26-000005.md) | [1,117](/filings/0000010795-26-000026.md) | [1,163](/filings/0000010795-26-000035.md) | [1,843 d](/filings/0000010795-25-000099.md) | [1,393](/filings/0000010795-26-000005.md) | [1,213](/filings/0000010795-26-000026.md) | [1,261](/filings/0000010795-26-000035.md) |
| Operating income | $m | [349 d](/filings/0000010795-25-000099.md) | [439](/filings/0000010795-25-000022.md) | [734](/filings/0000010795-25-000039.md) | [602](/filings/0000010795-25-000072.md) | [622 d](/filings/0000010795-25-000099.md) | [453](/filings/0000010795-26-000005.md) | [383](/filings/0000010795-26-000026.md) | [739](/filings/0000010795-26-000035.md) | [1,174 d](/filings/0000010795-25-000099.md) | [552](/filings/0000010795-26-000005.md) | [93.0](/filings/0000010795-26-000026.md) | [663](/filings/0000010795-26-000035.md) |
| Interest expense | $m | [113 d](/filings/0000010795-25-000099.md) | [111](/filings/0000010795-24-000019.md) | [125](/filings/0000010795-24-000039.md) | [137](/filings/0000010795-25-000072.md) | [155 d](/filings/0000010795-25-000099.md) | [155](/filings/0000010795-26-000005.md) | [150](/filings/0000010795-26-000026.md) | [152](/filings/0000010795-26-000035.md) | [155 d](/filings/0000010795-25-000099.md) | [153](/filings/0000010795-26-000005.md) | [149](/filings/0000010795-26-000026.md) | [132](/filings/0000010795-26-000035.md) |
| Income tax | $m | [28.0 d](/filings/0000010795-25-000099.md) | [77.0](/filings/0000010795-25-000022.md) | [96.0](/filings/0000010795-25-000039.md) | [13.0](/filings/0000010795-25-000072.md) | [114 d](/filings/0000010795-25-000099.md) | [3.0](/filings/0000010795-26-000005.md) | [43.0](/filings/0000010795-26-000026.md) | [118](/filings/0000010795-26-000035.md) | [52.0 d](/filings/0000010795-25-000099.md) | [11.0](/filings/0000010795-26-000005.md) | [76.0](/filings/0000010795-26-000026.md) | [102](/filings/0000010795-26-000035.md) |
| Net income | $m | [108 d](/filings/0000010795-25-000099.md) | [281](/filings/0000010795-25-000022.md) | [537](/filings/0000010795-25-000039.md) | [487](/filings/0000010795-25-000072.md) | [400 d](/filings/0000010795-25-000099.md) | [303](/filings/0000010795-26-000005.md) | [308](/filings/0000010795-26-000026.md) | [574](/filings/0000010795-26-000035.md) | [493 d](/filings/0000010795-25-000099.md) | [382](/filings/0000010795-26-000005.md) | [(311)](/filings/0000010795-26-000026.md) | [377](/filings/0000010795-26-000035.md) |
| Diluted EPS | $ per share | not reported | [0.96](/filings/0000010795-25-000022.md) | [1.85](/filings/0000010795-25-000039.md) | [1.68](/filings/0000010795-25-000072.md) | not reported | [1.04](/filings/0000010795-26-000005.md) | [1.07](/filings/0000010795-26-000026.md) | [2.00](/filings/0000010795-26-000035.md) | not reported | [1.34](/filings/0000010795-26-000005.md) | [(1.11)](/filings/0000010795-26-000026.md) | [1.37](/filings/0000010795-26-000035.md) |
| Basic EPS | $ per share | not reported | [0.97](/filings/0000010795-25-000022.md) | [1.85](/filings/0000010795-25-000039.md) | [1.68](/filings/0000010795-25-000072.md) | not reported | [1.05](/filings/0000010795-26-000005.md) | [1.07](/filings/0000010795-26-000026.md) | [2.00](/filings/0000010795-26-000035.md) | not reported | [1.34](/filings/0000010795-26-000005.md) | [(1.11)](/filings/0000010795-26-000026.md) | [1.37](/filings/0000010795-26-000035.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.4](/filings/0000010795-24-000084.md) | [1.2](/filings/0000010795-24-000019.md) | [2.3](/filings/0000010795-24-000039.md) | [4.5](/filings/0000010795-24-000067.md) | [1.7](/filings/0000010795-25-000099.md) | [0.7](/filings/0000010795-25-000022.md) | [0.7](/filings/0000010795-25-000039.md) | [0.7](/filings/0000010795-25-000072.md) | [0.6](/filings/0000010795-26-000035.md) | [0.7](/filings/0000010795-26-000005.md) | [0.8](/filings/0000010795-26-000026.md) | [0.7](/filings/0000010795-26-000035.md) |
| Current assets | $bn | [8.7](/filings/0000010795-24-000084.md) | [8.2](/filings/0000010795-24-000019.md) | [10.3](/filings/0000010795-24-000039.md) | [12.2](/filings/0000010795-24-000067.md) | [10.5](/filings/0000010795-25-000099.md) | [8.7](/filings/0000010795-25-000022.md) | [8.7](/filings/0000010795-25-000039.md) | [9.0](/filings/0000010795-25-000072.md) | [9.3](/filings/0000010795-26-000035.md) | [9.2](/filings/0000010795-26-000005.md) | [8.0](/filings/0000010795-26-000026.md) | [8.1](/filings/0000010795-26-000035.md) |
| Total assets | $bn | [52.8](/filings/0000010795-24-000084.md) | [52.3](/filings/0000010795-24-000019.md) | [54.2](/filings/0000010795-24-000039.md) | [55.6](/filings/0000010795-24-000067.md) | [57.3](/filings/0000010795-25-000099.md) | [54.7](/filings/0000010795-25-000022.md) | [54.5](/filings/0000010795-25-000039.md) | [54.9](/filings/0000010795-25-000072.md) | [55.3](/filings/0000010795-26-000035.md) | [54.8](/filings/0000010795-26-000005.md) | [50.8](/filings/0000010795-26-000026.md) | [50.7](/filings/0000010795-26-000035.md) |
| Current liabilities | $bn | [6.6](/filings/0000010795-24-000084.md) | [7.5](/filings/0000010795-24-000019.md) | [7.3](/filings/0000010795-24-000039.md) | [6.6](/filings/0000010795-24-000067.md) | [9.0](/filings/0000010795-25-000099.md) | [7.7](/filings/0000010795-25-000022.md) | [7.7](/filings/0000010795-25-000039.md) | [8.2](/filings/0000010795-25-000072.md) | [8.3](/filings/0000010795-26-000035.md) | [8.8](/filings/0000010795-26-000005.md) | [8.5](/filings/0000010795-26-000026.md) | [9.4](/filings/0000010795-26-000035.md) |
| Long-term debt | $bn | [14.7](/filings/0000010795-24-000084.md) | [14.1](/filings/0000010795-24-000019.md) | [16.0](/filings/0000010795-24-000039.md) | [18.1](/filings/0000010795-24-000067.md) | [17.9](/filings/0000010795-25-000099.md) | [17.4](/filings/0000010795-25-000022.md) | [17.7](/filings/0000010795-25-000039.md) | [17.5](/filings/0000010795-25-000072.md) | [17.6](/filings/0000010795-26-000035.md) | [16.9](/filings/0000010795-26-000005.md) | [14.7](/filings/0000010795-26-000026.md) | [13.5](/filings/0000010795-26-000035.md) |
| Current portion of debt | $bn | [1.1](/filings/0000010795-24-000084.md) | [2.0](/filings/0000010795-24-000019.md) | [2.0](/filings/0000010795-24-000039.md) | [1.2](/filings/0000010795-24-000067.md) | [2.2](/filings/0000010795-25-000099.md) | [1.3](/filings/0000010795-25-000022.md) | [1.6](/filings/0000010795-25-000039.md) | [1.8](/filings/0000010795-25-000072.md) | [1.6](/filings/0000010795-26-000035.md) | [2.6](/filings/0000010795-26-000005.md) | [2.6](/filings/0000010795-26-000026.md) | [3.3](/filings/0000010795-26-000035.md) |
| Shareholders' equity | $bn | [25.8](/filings/0000010795-24-000084.md) | [25.3](/filings/0000010795-24-000019.md) | [25.6](/filings/0000010795-24-000039.md) | [25.9](/filings/0000010795-24-000067.md) | [25.9](/filings/0000010795-25-000099.md) | [25.2](/filings/0000010795-25-000022.md) | [25.2](/filings/0000010795-25-000039.md) | [25.5](/filings/0000010795-25-000072.md) | [25.4](/filings/0000010795-26-000035.md) | [25.3](/filings/0000010795-26-000005.md) | [24.1](/filings/0000010795-26-000026.md) | [24.4](/filings/0000010795-26-000035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,325 d](/filings/0000010795-25-000099.md) | [855](/filings/0000010795-25-000022.md) | [514 d](/filings/0000010795-25-000039.md) | [1,297 d](/filings/0000010795-25-000072.md) | [1,178 d](/filings/0000010795-25-000099.md) | [693](/filings/0000010795-26-000005.md) | [(204) d](/filings/0000010795-26-000026.md) | [1,089 d](/filings/0000010795-26-000035.md) | [1,852 d](/filings/0000010795-25-000099.md) | [657](/filings/0000010795-26-000005.md) | [671 d](/filings/0000010795-26-000026.md) | [776 d](/filings/0000010795-26-000035.md) |
| Capital expenditure | $m | [294 d](/filings/0000010795-25-000099.md) | [116](/filings/0000010795-25-000022.md) | [134 d](/filings/0000010795-25-000039.md) | [179 d](/filings/0000010795-25-000072.md) | [296 d](/filings/0000010795-25-000099.md) | [105](/filings/0000010795-26-000005.md) | [114 d](/filings/0000010795-26-000026.md) | [164 d](/filings/0000010795-26-000035.md) | [377 d](/filings/0000010795-25-000099.md) | [108](/filings/0000010795-26-000005.md) | [125 d](/filings/0000010795-26-000026.md) | [143 d](/filings/0000010795-26-000035.md) |
| Dividends paid | $m | [265 d](/filings/0000010795-25-000099.md) | [275](/filings/0000010795-25-000022.md) | [275 d](/filings/0000010795-25-000039.md) | [275 d](/filings/0000010795-25-000072.md) | [275 d](/filings/0000010795-25-000099.md) | [302](/filings/0000010795-26-000005.md) | [298 d](/filings/0000010795-26-000026.md) | [299 d](/filings/0000010795-26-000035.md) | [297 d](/filings/0000010795-25-000099.md) | [299](/filings/0000010795-26-000005.md) | [290 d](/filings/0000010795-26-000026.md) | [286 d](/filings/0000010795-26-000035.md) |
| Share repurchases | $m | [0.0 d](/filings/0000010795-25-000099.md) | [500](/filings/0000010795-25-000022.md) | [0.0 d](/filings/0000010795-25-000039.md) | [0.0 d](/filings/0000010795-25-000072.md) | [0.0 d](/filings/0000010795-25-000099.md) | [750](/filings/0000010795-26-000005.md) | [0.0 d](/filings/0000010795-26-000026.md) | [0.0 d](/filings/0000010795-26-000035.md) | [250 d](/filings/0000010795-25-000099.md) | [250](/filings/0000010795-26-000005.md) | [2,000 d](/filings/0000010795-26-000026.md) | [0.0 d](/filings/0000010795-26-000035.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [285](/filings/0000010795-24-000019.md) | [286](/filings/0000010795-24-000039.md) | [288](/filings/0000010795-24-000067.md) | [291](/filings/0000010795-25-000022.md) | [290](/filings/0000010795-25-000039.md) | [290](/filings/0000010795-25-000072.md) | [290](/filings/0000010795-26-000005.md) | [288](/filings/0000010795-26-000026.md) | [287](/filings/0000010795-26-000035.md) | [286](/filings/0000010795-26-000005.md) | [281](/filings/0000010795-26-000026.md) | [275](/filings/0000010795-26-000035.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 272,386,800 at 2026-06-30, from the cover of the [10-Q filed 2026-08-06](/filings/0000010795-26-000035.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.